) was a big mover last session, as the company saw its shares rise
by over 8% on the day. The move came on solid volume too with far
more shares changing hands than in a normal session. This breaks
the recent trend of the stock, as it is now trading above the
volatile price range of $20.32 to $21.71 in the past one-month time
This generic drug company has seen a mixed track record when it
comes to estimate revision. One estimate each has moved up and down
in the last one month. The Zacks Consensus Estimate, however, has
remained unchanged over the same time period. The recent price
action is encouraging though, so make sure to keep a close watch on
this firm in the near future.
Akorn currently has a Zacks Rank #3 (Hold) while its
Some better performing stocks in the same industry include
Impax Laboratories Inc.
Supernus Pharmaceuticals, Inc.
), holding a Zacks Rank #1 (Strong Buy) and a Zacks Rank #2 (Buy),
respectively. Another stock in the broader healthcare sector worth
) with a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download
7 Best Stocks for the Next 30 Days
Click to get this free report >>
AKORN INC (AKRX): Free Stock Analysis Report
CYNOSURE INC-A (CYNO): Free Stock Analysis
IMPAX LABORATRS (IPXL): Free Stock Analysis
SUPERNUS PHARMA (SUPN): Free Stock Analysis
To read this article on Zacks.com click here.